Skip to main content
. Author manuscript; available in PMC: 2016 Apr 8.
Published in final edited form as: J Nucl Med. 2014 May 22;55(7):1185–1191. doi: 10.2967/jnumed.114.138701

Figure 2.

Figure 2

A: Ligand concentrations (ng/g of brain tissue) in the cerebellum (grey bar) and striatum (black bar) of Sprague-Dawley rats at 5, 20, 40 and 60 min (n = 4 rats per time point) following intravenous administration of LY2459989 (3 μg/g); B: Dose-receptor occupancy relationship of LY2459989 at KOR, MOR and DOR.